Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Novel Exploratory Study to Test Neoadjuvant Immunotherapy Combinations in Patients With Resectable Colon Cancer (NEST3)

NCT07595874 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT07595874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07595874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Novel Exploratory Study to Test Neoadjuvant Immunotherapy Combinations in Patients With Resectable Colon Cancer (NEST3)
Lead sponsor
City of Hope Medical Center
Phase
Phase 2
Overall status
Recruiting
Start date
December 27, 2026
Completion date
May 27, 2027
Enrollment
100 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

advanced colon adenocarcinoma, advanced colorectal adenocarcinoma, advanced rectal adenocarcinoma, stage iib colon cancer ajcc v8, stage iib rectal cancer ajcc v8, stage iic colon cancer ajcc v8, stage iic rectal cancer ajcc v8, stage iiia colon cancer ajcc v8, stage iiia rectal cancer ajcc v8, stage iiib colon cancer ajcc v8, stage iiib rectal cancer ajcc v8, stage iiic colon cancer ajcc v8, stage iiic rectal cancer ajcc v8